Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis

BACKGROUND: HER2-low expression breast cancer (BC) accounts for approximately 45%-55% of all BC cases. The purpose of this study was to investigate the prognostic difference between patients with HER2-low expression and HER2-zero BC. METHODS: An electronic search of Pubmed, Embase, Cochrane Library,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Tong, Wang, Dingyuan, Gao, Songlin, Wang, Xue, Yue, Jian, Kang, Yikun, Ju, Jie, Yang, Zixuan, Shuai, You, Yuan, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931719/
https://www.ncbi.nlm.nih.gov/pubmed/36816954
http://dx.doi.org/10.3389/fonc.2023.1100332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931719/
https://www.ncbi.nlm.nih.gov/pubmed/36816954
http://dx.doi.org/10.3389/fonc.2023.1100332

Ejemplares similares